Short communicationReinforcing versus anticonvulsant drugs: effects on intracranial self-stimulation rate–frequency M50 indices
Section snippets
Acknowledgements
This research was supported by grants from the National Sciences and Engineering Council (NSERC) of Canada.
References (49)
- et al.
GABA in the ventral tegmental area: differential regional effects on locomotion, aggression and food intake after microinjection of GABA agonists and antagonists
Life Sci.
(1979) - et al.
Self-administration of barbiturates and benzodiazepines: a review
Pharmacol. Biochem. Behav.
(1987) - et al.
Novel GABA agonists depress the reward effect of lateral hypothalamic stimulation in rats
Pharmacol. Biochem. Behav.
(1988) - et al.
The genetic animal model of reflex epilepsy in the Mongolian gerbil: differential efficacy of new anticonvulsive drugs and prototype antiepileptics
Pharmacol. Res. Commun.
(1987) - et al.
The anticonvulsant gabapentin decreases firing rates of substantia nigra pars reticulata neurons
Eur. J. Pharmacol.
(1996) - et al.
Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement
Pharmacol. Biochem. Behav.
(2000) - et al.
Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area
Pharmacol. Biochem. Behav.
(1979) - et al.
Effect of amphetamine and cocaine on seizure in lead-treated mice
Pharmacol. Biochem. Behav.
(1982) - et al.
Intravenous self-administration of pentobarbital and ethanol in rats
Pharmacol. Biochem. Behav.
(1985) - et al.
Quantitative determination of the effects of catecholaminergic agonists and antagonists on the rewarding efficacy of brain stimulation
Pharmacol. Biochem. Behav.
(1987)
The effects of amygdaloid stimulation on amphetamine-elicited locomotor sensitization
Brain Res. Bull.
Diazepam alters brain stimulation reward thresholds in seizure-prone sites
Behav. Brain Res.
Regional differences within the rat ventral tegmental area for muscimol self-infusions
Pharmacol. Biochem. Behav.
Chimeric GABAA/glycine receptors: expression and barbiturate pharmacology
Neuropharmacology
Drugs of abuse: anatomy pharmacology and function of reward pathways
Trends Pharmacol. Sci.
Anxiety anxiolytics and brain stimulation reinforcement
Neurosci. Biobehav. Rev.
Naloxone blocks the excitatory effect of ethanol and chlordiazepoxide on lateral hypothalamic self-stimulation behavior
Life Sci.
Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies
Behav. Brain Res.
Sensitization to the effects of repeated amphetamine administration on intracranial self-stimulation: evidence for changes in reward processes
Behav. Brain Res.
Involvement of a GABAergic mechanism in the anticonvulsant effect of pentobarbital against maximal electroshock-induced seizures in rats
Pharmacol. Biochem. Behav.
An analysis of the effects of amphetamine on brain self-stimulation behavior
Behav. Brain Res.
Pentobarbital induces a naloxone-reversible decrease in mesolimbic self-stimulation threshold
Pharmacol. Biochem. Behav.
Comparative studies of locomotor behavior following microinjections of muscimol into various sites in the paramedian tegmentum
Pharmacol. Biochem. Behav.
Action of drugs of abuse on brain reward systems
Pharmacol. Biochem. Behav.
Cited by (9)
Effects of mood stabilizers on brain reward processes in rats: Studies using the intracranial self-stimulation paradigm
2009, European NeuropsychopharmacologyEffects of gabapentin on cocaine self-administration, cocaine-triggered relapse and cocaine-enhanced nucleus accumbens dopamine in rats
2008, Drug and Alcohol DependenceCitation Excerpt :Such low doses of gabapentin (1–30 mg/kg) also failed to alter acute cocaine-induced hyperactivity or repeated cocaine-induced behavioral sensitization in rats (Itzhak and Martin, 2000; but see Filip et al., 2006). In contrast, one study reported that gabapentin (10–100 mg/kg) dose-dependently protected against cocaine (75 mg/kg)-induced seizures in mice (Gasior et al., 1999), which may result from a pharmacologically distinct (i.e., non-GABAergic) underlying mechanism (Bossert and Franklin, 2003). The present findings that gabapentin (25–200 mg/kg) failed to inhibit cocaine self-administration, cocaine-triggered relapse and cocaine-enhanced NAc DA suggest that gabapentin, at the doses tested, has little potential for altering cocaine's rewarding effects or cocaine craving and relapse at the human level.
The rewarding efficacy of brain stimulation and its modulation by dopaminergic drugs in young adult and old BN F344F1 rats
2008, Pharmacology Biochemistry and BehaviorEffect of diazepam on the runway method using priming stimulation of intracranial self stimulation behavior
2008, Journal of Pharmacological SciencesAssessing the value of the zebrafish conditioned place preference model for predicting human abuse potential
2017, Journal of Pharmacology and Experimental Therapeutics